Panacea Life Sciences Holdings, Inc.
PLSH· OTC
PLSHPanacea Life Sciences Holdings, Inc.
Filed Apr 15, 2021 · 10-K · 105 days after period end · 0001654954-21-004263
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $209.39K | $0.00 | $0.00 |
| Net Income | $714.75K | -$4.56M | -$1.11M | -$2.04M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Apr 15, 2021 · 105 d after period end
